Sclerosing Cholangitis

  • Kenichi Harada
  • Yasuni Nakanuma


IgG4-related sclerosing cholangitis is one of the major types of inflammation within the biliary tree and must be distinguished carefully from primary sclerosing cholangitis and other conditions. Typical cases of IgG4-related sclerosing cholangitis that accompany type 1 autoimmune pancreatitis or other classic organ system manifestations of IgG4-RD are well described. In addition, however, cases associated with atypical features, unusual concomitant diseases or syndromes, or malignancies have also been reported.

The finding of increased numbers of IgG4-positive plasma cells is not specific for IgG4-RD because such cellular infiltrates can be observed in multiple conditions, including cholangiocarcinoma. Important work in diagnostic criteria has been performed, but in the present state of knowledge, characterized by large gaps in understanding, diagnoses must often be made and treatment rendered on a case-by-case basis, with careful consideration of the clinical, serologic, radiologic, and pathological features; knowledge of disease in other organs; and close clinicopathological correlation.


Bile Duct Primary Sclerosing Cholangitis Autoimmune Hepatitis Sclerosing Cholangitis Bile Duct Injury 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Hamano H, Kawa S, Horiuchi A, Unno H, Furuya N, Akamatsu T, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med. 2001;344:732–8.PubMedCrossRefGoogle Scholar
  2. 2.
    Zen Y, Harada K, Sato Y, Tsuneyama K, Haratake J, Kurumaya H, et al. IgG4-related sclerosing cholangitis with and without hepatic inflammatory pseudotumor, and sclerosing pancreatitis-associated sclerosing cholangitis: do they belong to a spectrum of sclerosing pancreatitis? Am J Surg Pathol. 2004;28:1193–203.PubMedCrossRefGoogle Scholar
  3. 3.
    Hamano H, Kawa S, Uehara T, Ochi Y, Takayama M, Komatsu K, et al. Immunoglobulin G4-related lymphoplasmacytic sclerosing cholangitis that mimics infiltrating hilar cholangiocarcinoma: part of a spectrum of autoimmune pancreatitis? Gastrointest Endosc. 2005;62:152–7.PubMedCrossRefGoogle Scholar
  4. 4.
    Chari ST, Smyrk TC, Levy MJ, Topazian MD, Takahashi N, Zhang L, et al. Diagnosis of autoimmune pancreatitis: the Mayo Clinic experience. Clin Gastroenterol Hepatol. 2006;4:1010–6. quiz 1934.PubMedCrossRefGoogle Scholar
  5. 5.
    Ghazale A, Chari ST, Zhang L, Smyrk TC, Takahashi N, Levy MJ, et al. Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy. Gastroenterology. 2008;134:706–15.PubMedCrossRefGoogle Scholar
  6. 6.
    Kawakami H, Zen Y, Kuwatani M, Eto K, Haba S, Yamato H, et al. IgG4-related sclerosing cholangitis and autoimmune pancreatitis: histological assessment of biopsies from Vater’s ampulla and the bile duct. J Gastroenterol Hepatol. 2010;25:1648–55.PubMedCrossRefGoogle Scholar
  7. 7.
    Umemura T, Zen Y, Hamano H, Kawa S, Nakanuma Y, Kiyosawa K. Immunoglobin G4-hepatopathy: association of immunoglobin G4-bearing plasma cells in liver with autoimmune pancreatitis. Hepatology. 2007;46:463–71.PubMedCrossRefGoogle Scholar
  8. 8.
    Kawa S, Hamano H, Kiyosawa K. Pancreatitis. St. Louis: Elsevier; 2006.Google Scholar
  9. 9.
    Hirano K, Shiratori Y, Komatsu Y, Yamamoto N, Sasahira N, Toda N, et al. Involvement of the biliary system in autoimmune pancreatitis: a follow-up study. Clin Gastroenterol Hepatol. 2003;1:453–64.PubMedCrossRefGoogle Scholar
  10. 10.
    Kamisawa T, Funata N, Hayashi Y, Eishi Y, Koike M, Tsuruta K, et al. A new clinicopathological entity of IgG4-related autoimmune disease. J Gastroenterol. 2003;38:982–4.PubMedCrossRefGoogle Scholar
  11. 11.
    Umemura T, Zen Y, Hamano H, Ichijo T, Kawa S, Nakanuma Y, et al. IgG4 associated autoimmune hepatitis: a differential diagnosis for classical autoimmune hepatitis. Gut. 2007;56:1471–2.PubMedCrossRefGoogle Scholar
  12. 12.
    Hennes EM, Zeniya M, Czaja AJ, Pares A, Dalekos GN, Krawitt EL, et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology. 2008;48:169–76.PubMedCrossRefGoogle Scholar
  13. 13.
    Takigawa H. National survey of PSC in Japan (in Japanese). Kan Tan Sui. 2004;49:193–8.Google Scholar
  14. 14.
    Nakazawa T, Ohara H, Yamada T, Ando H, Sano H, Kajino S, et al. Atypical primary sclerosing cholangitis cases associated with unusual pancreatitis. Hepatogastroenterology. 2001;48:625–30.PubMedGoogle Scholar
  15. 15.
    Nakazawa T, Ohara H, Sano H, Aoki S, Kobayashi S, Okamoto T, et al. Cholangiography can discriminate sclerosing cholangitis with autoimmune pancreatitis from primary sclerosing cholangitis. Gastrointest Endosc. 2004;60:937–44.PubMedCrossRefGoogle Scholar
  16. 16.
    Kimura Y, Harada K, Nakanuma Y. Pathologic significance of immunoglobulin G4-positive plasma cells in extrahepatic cholangiocarcinoma. Hum Pathol. 2012;43:2149–56.PubMedCrossRefGoogle Scholar
  17. 17.
    Harada K, Shimoda S, Kimura Y, Sato Y, Ikeda H, Igarashi S, et al. Significance of IgG4-positive cells in extrahepatic cholangiocarcinoma: Molecular mechanism of IgG4 reaction in cancer tissue. Hepatology. 2012;56:157–64.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Japan 2014

Authors and Affiliations

  1. 1.Department of Human PathologyKanazawa University School of MedicineKanazawaJapan

Personalised recommendations